Valeria Cernaro

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Topics

Peritoneal Dialysis

Systematic Review

Chronic Kidney Disease

Top Venues

Clinics and practice

International urology and nephrology

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Vincenzo Calabrese, Alessandra Farina, Veronica Maressa, Valeria Cernaro, Guido Gembillo, Roberta Maria Messina, Elisa Longhitano, Cinzia Ferio, Emmanuele Venanzi Rullo, Domenico Santoro
Differences in Efficacy between Antibacterial Lock Therapy and the Standard of Care for CVC-Related Infections: A Systematic Review and Meta-Analysis. Clinics and practice 14 (4) (2024)
Vincenzo Calabrese, Alessandra Farina, Veronica Maressa, Valeria Cernaro, Guido Gembillo, Roberta Maria Messina, Elisa Longhitano, Cinzia Ferio, Emmanuele Venanzi Rullo, Domenico Santoro
Differences in Efficacy between Antibacterial Lock Therapy and the Standard of Care for CVC-Related Infections: A Systematic Review and Meta-Analysis. Clinics and practice 14 (4) (2024)
Vincenzo Calabrese, Alessandra Farina, Veronica Maressa, Valeria Cernaro, Guido Gembillo, Roberta Maria Messina, Elisa Longhitano, Cinzia Ferio, Emmanuele Venanzi Rullo, Domenico Santoro
Differences in Efficacy between Antibacterial Lock Therapy and the Standard of Care for CVC-Related Infections: A Systematic Review and Meta-Analysis. Clinics and practice 14 (4) (2024)
Elisa Longhitano, Paola Muscolino, Claudia Lo Re, Serena Ausilia Ferrara, Valeria Cernaro, Guido Gembillo, Dalila Tessitore, Desirèe Speranza, Francesco Figura, Mariacarmela Santarpia, Nicola Silvestris, Domenico Santoro, Tindara Franchina
Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine. Cancers 15 (6) (2023)
Chiara Casuscelli, Elisa Longhitano, Veronica Maressa, Silvia Di Carlo, Luigi Peritore, Simone Di Lorenzo, Vincenzo Calabrese, Valeria Cernaro, Domenico Santoro
Autoimmunity and Infection in Glomerular Disease. Microorganisms 11 (9) (2023)
Valeria Cernaro, Michela Calderone, Guido Gembillo, Vincenzo Calabrese, Chiara Casuscelli, Claudia Lo Re, Elisa Longhitano, Domenico Santoro
Phosphate Control in Peritoneal Dialysis Patients: Issues, Solutions, and Open Questions. Nutrients 15 (14) (2023)
Elisa Longhitano, Paola Muscolino, Claudia Lo Re, Serena Ausilia Ferrara, Valeria Cernaro, Guido Gembillo, Dalila Tessitore, Desirèe Speranza, Francesco Figura, Mariacarmela Santarpia, Nicola Silvestris, Domenico Santoro, Tindara Franchina
Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine. Cancers 15 (6) (2023)
Valeria Cernaro, Vincenzo Calabrese, Saverio Loddo, Roberta Corsaro, Vincenzo Macaione, Valentina Teresa Ferlazzo, Rosalia Maria Cigala, Francesco Crea, Concetta De Stefano, Guido Gembillo, Adolfo Romeo, Elisa Longhitano, Domenico Santoro, Michele Buemi, Salvatore Benvenga
Indole-3-acetic acid correlates with monocyte-to-high-density lipoprotein (HDL) ratio (MHR) in chronic kidney disease patients. International urology and nephrology 54 (9) (2022)
Valeria Cernaro, Saverio Loddo, Vincenzo Macaione, Valentina Teresa Ferlazzo, Rosalia Maria Cigala, Francesco Crea, Concetta De Stefano, Antonina Rita Rosalia Genovese, Guido Gembillo, Davide Bolignano, Domenico Santoro, Roberto Vita, Michele Buemi, Salvatore Benvenga
RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitus. International urology and nephrology 52 (6) (2020)
Guido Gembillo, Rossella Siligato, Valeria Cernaro, Domenico Santoro
Complement Inhibition Therapy and Dialytic Strategies in Paroxysmal Nocturnal Hemoglobinuria: The Nephrologist's Opinion. Journal of clinical medicine 9 (5) (2020)
Valeria Cernaro, Sebastiano Calimeri, Alfredo Laudani, Domenico Santoro
Clinical Evaluation of the Safety, Efficacy and Tolerability of Lanthanum Carbonate in the Management of Hyperphosphatemia in Patients with End-Stage Renal Disease. Therapeutics and clinical risk management 16 (2020)
Roberto Vita, Valeria Cernaro, Salvatore Benvenga
Stress-induced hashitoxicosis: case report and relative HLA serotype and genotype. Revista da Associacao Medica Brasileira (1992) 65 (6) (2019)
Valeria Cernaro, Giuseppe Coppolino, Luca Visconti, Laura Rivoli, Antonio Lacquaniti, Domenico Santoro, Antoine Buemi, Saverio Loddo, Michele Buemi
Erythropoiesis and chronic kidney disease-related anemia: From physiology to new therapeutic advancements. Medicinal research reviews 39 (2) (2018)
Valeria Cernaro, Giovanni Tripepi, Luca Visconti, Antonio Lacquaniti, Gaetano Montalto, Adolfo Romeo, Domenica Cimadoro, Giuseppe Costantino, Francesco Torre, Domenico Santoro, Michele Buemi, null null
Convective Dialysis Reduces Mortality Risk: Results From a Large Observational, Population-Based Analysis. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 22 (5) (2018)
Ramona Nicotera, Giuseppe Leonardi, Alberto Castagna, Valeria Cernaro, Giuseppe Coppolino, null null
Wernicke-Korsakoff Syndrome in End-Stage Renal Disease: A Case Report. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 22 (6) (2018)
Anna Pisano, Valeria Cernaro, Guido Gembillo, Graziella D'Arrigo, Michele Buemi, Davide Bolignano
Xanthine Oxidase Inhibitors for Improving Renal Function in Chronic Kidney Disease Patients: An Updated Systematic Review and Meta-Analysis. International journal of molecular sciences 18 (11) (2017)
Valeria Cernaro, Maria A Medici, Federica Bianco, Domenico Santoro, Antonio Lacquaniti, Adolfo Romeo, Silvia Lucisano, Antoine Buemi, Michele Buemi
Opposite actions of urotensin II and relaxin-2 on cellular expression of fibronectin in renal fibrosis: A preliminary experimental study. Clinical and experimental pharmacology & physiology 44 (10) (2017)